Artificial intelligence (AI) has the potential to streamline medical product R&D processes in a multitude of ways, from assisting in robotic surgery to rapidly analyzing large swathes of clinical trial data.
However, with great potential comes great risk, at least in the eyes of the European Commission, which in April 2021 proposed the EU AI Act, which would be the world’s...